☰

Robyn Levine, Ph.D. - Publications

Affiliations: 
2008 Astrophysical and Planetary Sciences University of Colorado, Boulder, Boulder, CO, United States 
Area:
Astronomy and Astrophysics
Tree Info Similar researchers PubMed Report error

58 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Heimbruch KE, Fisher JB, Stelloh CT, Phillips E, Reimer MH, Wargolet AJ, Meyer AE, Pulakanti K, Viny AD, Loppnow JJ, Levine RL, Pulikkan JA, Zhu N, Rao S. DOT1L inhibitors block abnormal self-renewal induced by cohesin loss. Scientific Reports. 11: 7288. PMID 33790356 DOI: 10.1038/s41598-021-86646-9  0.316
2020 Miles LA, Bowman RL, Merlinsky TR, Csete IS, Ooi AT, Durruthy-Durruthy R, Bowman M, Famulare C, Patel MA, Mendez P, Ainali C, Demaree B, Delley CL, Abate AR, Manivannan M, ... ... Levine RL, et al. Single-cell mutation analysis of clonal evolution in myeloid malignancies. Nature. PMID 33116311 DOI: 10.1038/s41586-020-2864-x  0.314
2020 Pastore F, Krishnan A, Hammarén HM, Silvennoinen O, Yan B, Levine RL. JAK2S523L, a novel gain-of-function mutation in a critical autoregulatory residue in JAK2V617F- MPNs. Blood Advances. 4: 4554-4559. PMID 32956452 DOI: 10.1182/bloodadvances.2019001283  0.303
2019 Miles LA, Bowman RL, Merlinsky TR, Ooi A, Mendez P, Famulare C, Patel MA, Bolton K, Palmisiano N, Carroll MP, Papaemmanuil E, Zehir A, Meyer SE, Viny AD, Levine RL. Single Cell DNA Sequencing Identifies Combinatorial Mutation Patterns and Clonal Architecture in Myeloid Malignancies Blood. 134: 913-913. DOI: 10.1182/Blood-2019-128763  0.326
2018 Pronier E, Bowman RL, Ahn J, Glass J, Kandoth C, Merlinsky TR, Whitfield JT, Durham BH, Gruet A, Hanasoge Somasundara AV, Rampal R, Melnick A, Koche RP, Taylor BS, Levine RL. Genetic and epigenetic evolution as a contributor to WT1-mutant leukemogenesis. Blood. PMID 30064973 DOI: 10.1182/Blood-2018-03-837468  0.309
2018 McKenney AS, Lau AN, Somasundara AVH, Spitzer B, Intlekofer AM, Ahn J, Shank K, Rapaport FT, Patel MA, Papalexi E, Shih AH, Chiu A, Freinkman E, Akbay EA, Steadman M, ... ... Levine RL, et al. JAK2/IDH-mutant-driven myeloproliferative neoplasm is sensitive to combined targeted inhibition. The Journal of Clinical Investigation. PMID 29355841 DOI: 10.1172/Jci94516  0.333
2018 Santos FP, Getta B, Masarova L, Famulare C, Schulman J, Puga RD, Paiva RdMA, Hamerschlak N, Kantarjian HM, Levine RL, Campregher PV, Rampal RK, Verstovsek S. Prognostic Impact of Activating Mutations of the NRAS/KRAS Genes in Patients with Primary and Post-Essential Thrombocythemia (ET)/Polycythemia Vera (PV) Myelofibrosis (MF) Blood. 132: 1756-1756. DOI: 10.1182/blood-2018-99-120091  0.307
2018 Spitzer B, Gundem G, Farnoud N, Millard N, McGovern E, Patel M, Levine M, Medina J, Zhou Y, Arango Ossa JE, Walsh MF, Levine RL, Cheung IY, Armstrong SA, Cheung NV, et al. Early Detection and Molecular Characterization of Therapy-Related Leukemia in Children Reveals Patterns of Disease Transformation and Guides Future Surveillance Protocols Blood. 132: 291-291. DOI: 10.1182/Blood-2018-99-120005  0.302
2018 Xiao W, Goldberg AD, Ball B, Famulare C, Pastore F, Tallman MS, Zhang Y, Arcila ME, Papaemmanuil E, Levine RL, Roshal M. PHF6 Mutations Are Mutually Exclusive to TP53 Mutations, and Define a Distinct Subgroup of Secondary Acute Myeloid Leukemia Associated with a Primitive Stem/Progenitor Immunophenotype, Absent Complex Karyotype and Relatively Better Outcomes Blood. 132: 2788-2788. DOI: 10.1182/BLOOD-2018-99-118985  0.319
2018 Meyer AE, Stelloh C, Fisher JB, Pulakanti K, Vassiliou GS, Viny AD, Levine RL, Rao S. Combinatorial Genetics Uncovers Novel Targets for the Treatment of Npm1/Cohesin Mutated AML Blood. 132: 2598-2598. DOI: 10.1182/blood-2018-99-113011  0.344
2017 Viny AD, Levine RL. Cohesin mutations in myeloid malignancies made simple. Current Opinion in Hematology. PMID 29278534 DOI: 10.1097/MOH.0000000000000405  0.312
2017 Kunimoto H, Meydan C, Nazir A, Whitfield J, Shank K, Rapaport F, Maher R, Pronier E, Meyer SC, Garrett-Bakelman FE, Tallman M, Melnick A, Levine RL, Shih AH. Cooperative Epigenetic Remodeling by TET2 Loss and NRAS Mutation Drives Myeloid Transformation and MEK Inhibitor Sensitivity. Cancer Cell. PMID 29275866 DOI: 10.1016/J.Ccell.2017.11.012  0.326
2017 Dunbar A, Nazir A, Levine R. Overview of Transgenic Mouse Models of Myeloproliferative Neoplasms (MPNs). Current Protocols in Pharmacology. 77: 14.40.1-14.40.19. PMID 28640953 DOI: 10.1002/cpph.23  0.306
2017 Shih AH, Meydan C, Shank K, Garrett-Bakelman FE, Ward PS, Intlekofer A, Nazir A, Stein E, Knapp K, Glass J, Travins J, Straley K, Gliser C, Mason C, Yen K, ... ... Levine RL, et al. Combination Targeted Therapy to Disrupt Aberrant Oncogenic Signaling and Reverse Epigenetic Dysfunction in IDH2- and TET2-Mutant Acute Myeloid Leukemia. Cancer Discovery. PMID 28193779 DOI: 10.1158/2159-8290.Cd-16-1049  0.31
2017 Quek L, David M, Kennedy A, Metzner M, Amatangelo M, Shih AH, Stoilova B, Karamitros D, Quivoron C, Heiblig M, Willekens C, Saada V, Peniket A, Bernard O, Agresta S, ... ... Levine RL, et al. Clonal Heterogeneity in Differentiation Response and Resistance to the IDH2 Inhibitor Enasidenib in Acute Myeloid Leukemia Blood. 130: 724-724. DOI: 10.1182/BLOOD.V130.SUPPL_1.724.724  0.323
2016 Watts JM, Dumitriu B, Hilden P, Kishtagari A, Rapaport F, Chen C, Ahn J, Devlin SM, Stein EM, Rampal R, Levine RL, Young N, Tallman MS. Telomere length and associations with somatic mutations and clinical outcomes in acute myeloid leukemia. Leukemia Research. 49: 62-65. PMID 27568819 DOI: 10.1016/J.Leukres.2016.07.013  0.301
2016 Khwaja A, Bjorkholm M, Gale RE, Levine RL, Jordan CT, Ehninger G, Bloomfield CD, Estey E, Burnett A, Cornelissen JJ, Scheinberg DA, Bouscary D, Linch DC. Acute myeloid leukaemia. Nature Reviews. Disease Primers. 2: 16010. PMID 27159408 DOI: 10.1038/nrdp.2016.10  0.305
2016 Rapaport F, de Massy MR, al Hinai A, Sanders MA, Hricik T, Sheridan C, Lee TC, Neelamraju Y, Patel J, Chung SS, Becker MW, Lewis ID, D'Andrea R, Bullinger L, Döhner K, ... ... Levine RL, et al. Changes of the Mutational Landscape in Relapsed Acute Myeloid Leukemia Blood. 128: 599-599. DOI: 10.1182/Blood.V128.22.599.599  0.332
2016 Kunimoto H, Meydan C, Nazir A, Shank K, Maher R, Rapaport F, Pronier E, Melnick A, Levine RL, Shih AH. Cooperative Epigenetic Remodeling By TET2 Loss and NRAS Mutation Drives Myeloid Transformation and MEK Inhibitor Sensitivity Blood. 128: 433-433. DOI: 10.1182/BLOOD.V128.22.433.433  0.337
2016 Getta BM, Ghosh A, Coombs CC, Devlin S, Arcila M, Mohanty A, Levine RL, Tallman MS, Jakubowski AA, Giralt SA, Hanash AM. TP53 Mutations in AML Predict Adverse Outcome in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant Blood. 128: 3481-3481. DOI: 10.1182/Blood.V128.22.3481.3481  0.322
2015 Coombs CC, Tallman MS, Levine RL. Molecular therapy for acute myeloid leukaemia. Nature Reviews. Clinical Oncology. PMID 26620272 DOI: 10.1038/nrclinonc.2015.210  0.301
2015 Shih AH, Jiang Y, Meydan C, Shank K, Pandey S, Barreyro L, Antony-Debre I, Viale A, Socci N, Sun Y, Robertson A, Cavatore M, de Stanchina E, Hricik T, Rapaport F, ... ... Levine RL, et al. Mutational cooperativity linked to combinatorial epigenetic gain of function in acute myeloid leukemia. Cancer Cell. 27: 502-15. PMID 25873173 DOI: 10.1016/J.Ccell.2015.03.009  0.322
2015 Chen L, Chen W, Mysliwski M, Serio J, Ropa J, Abulwerdi FA, Chan RJ, Patel JP, Tallman MS, Paietta E, Melnick A, Levine RL, Abdel-Wahab O, Nikolovska-Coleska Z, Muntean AG. Mutated Ptpn11 alters leukemic stem cell frequency and reduces the sensitivity of acute myeloid leukemia cells to Mcl1 inhibition. Leukemia. 29: 1290-300. PMID 25650089 DOI: 10.1038/Leu.2015.18  0.322
2015 Woods BA, Levine RL. The role of mutations in epigenetic regulators in myeloid malignancies. Immunological Reviews. 263: 22-35. PMID 25510269 DOI: 10.1111/imr.12246  0.314
2015 Smith CC, Viny AD, Massi ES, Kandoth C, Socci ND, Hsu H, West B, Bollag G, Taylor BS, Levine RL, Shah NP. Recurrent Mutations in CCND3 Confer Clinical Resistance to FLT3 Inhibitors Blood. 126: 677-677. DOI: 10.1182/Blood.V126.23.677.677  0.318
2015 Park JH, Chung SS, Durham B, Chung YR, Scott S, Getta B, Kim E, Saven A, Stone RM, Rai KR, Grever MR, Altman JK, Rosen N, Levine RL, Berger M, et al. Diverse Mechanisms of Vemurafenib Resistance in BRAF-Mutant Hairy Cell Leukemia Blood. 126: 449-449. DOI: 10.1182/BLOOD.V126.23.449.449  0.304
2015 Coombs CC, Devlin S, Dixit S, Mohanty A, Knapp KM, Arcila M, Klimek VM, Tallman MS, Levine RL, Rampal RK, Rapaport F. Response to Hypomethylating Agent Therapy in Acute Myeloid Leukemia Based upon Mutations in the DNA Methylation Pathway Blood. 126: 2522-2522. DOI: 10.1182/Blood.V126.23.2522.2522  0.309
2015 Rapaport F, Patel J, He J, Brennan TA, Nahas M, Balassubramanian S, Otto G, Lipson D, Stephens P, Miller VA, Racevskis J, Litzow MR, Wiernik PH, Goldstone AH, Luger S, ... ... Levine RL, et al. Integrated DNA/RNA Profiling for Somatic Alterations in Adult B-Cell ALL Blood. 126: 1422-1422. DOI: 10.1182/Blood.V126.23.1422.1422  0.31
2015 Przychodzen B, Gu X, You D, Hirsch CM, Clemente MJ, Viny AD, Levine RL, Haferlach T, Maggendorfer M, Sekeres MA, Carraway HE, Nazha A, Enane F, Maciejewski JP. PHF6 - Somatic Mutations and Their Role in Pathophysiology of MDS and AML Blood. 126: 1259-1259. DOI: 10.1182/Blood.V126.23.1259.1259  0.325
2015 Hatlen MA, Arora K, Vacic V, Grabowska EA, Liao W, Riley-Gillis B, Oschwald DM, Wang L, Joergens JE, Shih AH, Rapaport F, Gu S, Voza F, Asai T, Neel B, ... ... Levine RL, et al. Integrative Analysis of the Mutational Landscape of Mouse and Human AML Identifies Functionally Relevant Leukemia Disease Alleles Blood. 126: 1247-1247. DOI: 10.1182/blood.v126.23.1247.1247  0.331
2014 Thota S, Viny AD, Makishima H, Spitzer B, Radivoyevitch T, Przychodzen B, Sekeres MA, Levine RL, Maciejewski JP. Genetic alterations of the cohesin complex genes in myeloid malignancies. Blood. 124: 1790-8. PMID 25006131 DOI: 10.1182/blood-2014-04-567057  0.304
2014 Rampal R, Al-Shahrour F, Abdel-Wahab O, Patel JP, Brunel JP, Mermel CH, Bass AJ, Pretz J, Ahn J, Hricik T, Kilpivaara O, Wadleigh M, Busque L, Gilliland DG, Golub TR, ... ... Levine RL, et al. Integrated genomic analysis illustrates the central role of JAK-STAT pathway activation in myeloproliferative neoplasm pathogenesis. Blood. 123: e123-33. PMID 24740812 DOI: 10.1182/Blood-2014-02-554634  0.314
2014 Viny AD, Levine RL. Genetics of myeloproliferative neoplasms. Cancer Journal (Sudbury, Mass.). 20: 61-5. PMID 24445766 DOI: 10.1097/PPO.0000000000000013  0.314
2014 Rampal RK, Alkalin A, Madzo J, Vasanthakumar A, Pronier E, Patel JP, Li Y, Ahn J, Abdel-Wahab O, Shih AH, Lu C, Ward P, Tsai JJ, Hricik T, Tallman J, ... ... Levine RL, et al. DNA Hydroxymethylation Profiling Reveals That WT1 Mutations Result in Loss of TET2 Function in Acute Myeloid Leukemia Blood. 124: 365-365. DOI: 10.1182/BLOOD.V124.21.365.365  0.316
2014 Chen L, Chen W, Mysliwski M, Serio J, Ropa J, Abulwerdi F, Chan RJ, Patel JP, Tallman MS, Paietta EM, Melnick AM, Levine RL, Abdel-Wahab O, Nikolovska-Coleska Z, Muntean AG. Hyperactive Ptpn11 Mutations Alters Leukemic Stem Cell Frequency through Mcl-1 Overexpression Blood. 124: 3565-3565. DOI: 10.1182/Blood.V124.21.3565.3565  0.324
2014 Watts JM, Dumitriu B, Hilden P, Chen C, Rapaport F, Kishtagari A, Ahn J, Devlin SM, Rampal RK, Levine RL, Young NS, Tallman MS. Telomere Length Is Associated with Specific Mutations and Mutation Classes in Patients with Acute Myeloid Leukemia Blood. 124: 2280-2280. DOI: 10.1182/Blood.V124.21.2280.2280  0.305
2014 Gardner JR, Nahas M, He J, Aumann S, Gonen M, Patel M, Knapp KM, Palomba ML, Yelensky R, Donahue AL, Otto G, Arcila M, Lamanna N, Frattini MG, Dogan A, ... ... Levine RL, et al. Genomic Analysis of Serial Samples from CLL Patients Identifies Clonal Events Associated with Disease Progression Blood. 124: 1954-1954. DOI: 10.1182/blood.v124.21.1954.1954  0.311
2013 Levine RL. Molecular pathogenesis of AML: translating insights to the clinic. Best Practice & Research. Clinical Haematology. 26: 245-8. PMID 24309525 DOI: 10.1016/j.beha.2013.10.003  0.328
2013 Abdel-Wahab O, Gao J, Adli M, Dey A, Trimarchi T, Chung YR, Kuscu C, Hricik T, Ndiaye-Lobry D, Lafave LM, Koche R, Shih AH, Guryanova OA, Kim E, Li S, ... ... Levine RL, et al. Deletion of Asxl1 results in myelodysplasia and severe developmental defects in vivo. The Journal of Experimental Medicine. 210: 2641-59. PMID 24218140 DOI: 10.1084/Jem.20131141  0.308
2013 Abdel-Wahab O, Levine RL. Mutations in epigenetic modifiers in the pathogenesis and therapy of acute myeloid leukemia. Blood. 121: 3563-72. PMID 23640996 DOI: 10.1182/blood-2013-01-451781  0.311
2013 Lesokhin A, Gonen M, Redling K, Lendvai N, Hassoun H, Landau H, Chung DJ, Koehne G, Patel M, Brennan KW, Wang K, Sanford EM, Brennan T, Otto GA, Nahas MK, ... ... Levine RL, et al. Pilot Study To Evaluate The Prevalence Of Actionable Oncogenic Mutations In Patients With Relapsed Refractory Multiple Myeloma Blood. 122: 755-755. DOI: 10.1182/BLOOD.V122.21.755.755  0.336
2013 Shih AH, Jiang Y, Shank K, Pandey S, Viale A, Sun Y, Socci N, Robertson A, de Stanchina E, Hricik T, Rapaport F, Woods B, Cimmino L, Barreyro L, Steidl U, ... ... Levine RL, et al. Epigenetic Profiling Of Leukemia Stem Cells In a Model Of TET2/FLT3-Mutant AML Blood. 122: 476-476. DOI: 10.1182/Blood.V122.21.476.476  0.327
2013 Rampal RK, Devlin SM, Mckenney AS, Knapp KM, Patel M, Wang K, Nahas MK, Yelensky R, Otto GA, Lipson D, Stephens PJ, Miller VA, Manshouri T, Verstovsek S, Levine RL. High-Throughput Mutational Profiling Of Post-Myeloproliferative Neoplasm Acute Myeloid Leukemia Reveals Frequent Mutations In NRAS In JAK2V617F-Negative Post-MPN AML Blood. 122: 4098-4098. DOI: 10.1182/Blood.V122.21.4098.4098  0.341
2013 Gardner JR, Nahas MK, He J, Patel M, Knapp KM, Palomba ML, Yelensky R, Donahue AL, Otto GA, Arcila M, Dogan A, Park JH, Zelenetz AD, Lipson D, Tallman MS, ... Levine RL, et al. Extensive High-Depth Sequencing Of Longitudinal CLL Samples Identifies Frequent Mutations In MAP Kinase Signaling and Novel Mutations Activating Notch and Beta-Catenin Blood. 122: 2858-2858. DOI: 10.1182/BLOOD.V122.21.2858.2858  0.321
2013 Hanash AM, Devlin SM, Maloy M, Knapp KM, Miller VA, Lipson D, Stephens PJ, Otto GA, Yelensky R, Nahas MK, Wang K, Levine RL, van den Brink MR, Jakubowski AA. Mutational Profiling Of Myeloid Malignancies For Prediction Of Disease Relapse Following Allogeneic Stem Cell Transplantation Blood. 122: 2096-2096. DOI: 10.1182/Blood.V122.21.2096.2096  0.331
2013 Rampal RK, Devlin SM, Patel JP, Knapp KM, Patel M, Greenbowe JR, Young LE, He J, Wang K, Nahas MK, Yelensky R, Otto GA, Lipson D, Stephens PJ, Miller VA, ... Levine RL, et al. Integrated Genetic Profiling Of JAK2 Wildtype Chronic-Phase Myeloproliferative Neoplasms Blood. 122: 1588-1588. DOI: 10.1182/Blood.V122.21.1588.1588  0.33
2012 Abdel-Wahab O, Tefferi A, Levine RL. Role of TET2 and ASXL1 mutations in the pathogenesis of myeloproliferative neoplasms. Hematology/Oncology Clinics of North America. 26: 1053-64. PMID 23009937 DOI: 10.1016/j.hoc.2012.07.006  0.311
2012 Shih AH, Abdel-Wahab O, Patel JP, Levine RL. The role of mutations in epigenetic regulators in myeloid malignancies. Nature Reviews. Cancer. 12: 599-612. PMID 22898539 DOI: 10.1038/nrc3343  0.306
2012 Zhang SJ, Rampal R, Manshouri T, Patel J, Mensah N, Kayserian A, Hricik T, Heguy A, Hedvat C, Gönen M, Kantarjian H, Levine RL, Abdel-Wahab O, Verstovsek S. Genetic analysis of patients with leukemic transformation of myeloproliferative neoplasms shows recurrent SRSF2 mutations that are associated with adverse outcome. Blood. 119: 4480-5. PMID 22431577 DOI: 10.1182/blood-2011-11-390252  0.317
2012 Meyer J, Wang J, Hogan LE, Patel J, Tang Z, Zumbo P, Li S, Zavadil J, Levine RL, Cardozo T, Hunger S, Raetz EA, Morrison DJ, Mason C, Carroll WL. Relapse-specific mutations in cytosolic 5’-nucleotidase II in childhood acute lymphoblastic leukemia. Journal of Clinical Oncology. 30: 9507-9507. DOI: 10.1200/Jco.2012.30.15_Suppl.9507  0.317
2011 Abdel-Wahab O, Patel J, Levine RL. Clinical implications of novel mutations in epigenetic modifiers in AML. Hematology/Oncology Clinics of North America. 25: 1119-33. PMID 22093580 DOI: 10.1016/j.hoc.2011.09.013  0.321
2011 Abdel-Wahab O, Adli M, Saunders L, Gao J, Shih AH, Pandey S, Jaffe J, Zhao X, Perna F, Carroll M, Melnick A, Nimer SD, Aifantis I, Bernstein B, Levine RL. ASXL1 Mutations Promote Myeloid Transformation Through Inhibition of PRC2-Mediated Gene Repression Blood. 118: 405-405. DOI: 10.1182/Blood.V118.21.405.405  0.334
2010 Figueroa ME, Abdel-Wahab O, Lu C, Ward PS, Patel J, Shih A, Li Y, Bhagwat N, Vasanthakumar A, Fernandez HF, Tallman MS, Sun Z, Wolniak K, Peeters JK, Liu W, ... ... Levine RL, et al. Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation. Cancer Cell. 18: 553-67. PMID 21130701 DOI: 10.1016/J.Ccr.2010.11.015  0.305
2010 Patel JP, Abdel-Wahab O, Gonen M, Figueroa ME, Fernandez HF, Sun Z, Racevskis J, Van lierberghe P, Dolgalev I, Cheng J, Viale A, Socci N, Heguy A, Ketterling R, Gallagher RE, ... ... Levine R, et al. High-Throughput Mutational Profiling In AML: Mutational Analysis of the ECOG E1900 Trial Blood. 116: 851-851. DOI: 10.1182/Blood.V116.21.851.851  0.303
2009 Abdel-Wahab O, Mullally A, Hedvat C, Garcia-Manero G, Patel J, Wadleigh M, Malinge S, Yao J, Kilpivaara O, Bhat R, Huberman K, Thomas S, Dolgalev I, Heguy A, Paietta E, ... ... Levine RL, et al. Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies. Blood. 114: 144-7. PMID 19420352 DOI: 10.1182/Blood-2009-03-210039  0.309
2007 Brown JR, Levine R, Raderschall E, Thompson C, Gilliland DG, Freedman AS. Systematic Genomic Screen for Tyrosine Kinase Mutations in CLL. Blood. 110: 2069-2069. DOI: 10.1182/BLOOD.V110.11.2069.2069  0.309
2007 Lee BH, Tothova Z, Levine RL, Anderson K, Buza-Vidas N, Cullen DE, McDowell EP, Adelsperger J, Frohling S, Huntly BJ, Beran M, Jacobsen SE, Gilliland DG. Leukemogenic FLT3 Mutations Confer Enhanced Proliferation and Survival Properties to Multipotent Progenitor Cells in a Murine Model of Chronic Myelomonocytic Leukemia. Blood. 110: 1613-1613. DOI: 10.1182/BLOOD.V110.11.1613.1613  0.327
2005 Ebert BL, Levine RL, Wadleigh M, Brunet J, Pretz JL, Buque L, Lee SJ, Gilliland DG, Golub TR. Characterization of Distinct Molecular Signatures in Myeloproliferative Diseases with the JAK2V617F Mutation and Wild Type JAK2. Blood. 106: 119-119. DOI: 10.1182/BLOOD.V106.11.119.119  0.306
Show low-probability matches.